• Home>
  • Stocks>
  • Senores Pharmaceuticals Ltd Share Price
Senores Pharmaceuticals Ltd share price logo

Senores Pharmaceuticals Ltd Share Price

NSE: SENORES

BSE: 544319

Small Cap

Healthcare Sector

₹767.05

-20.85

(-2.65%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Senores Pharmaceuticals Ltd Stock Performance

as on November 11, 2025 at 2:59 pm IST

  • Day's Low

    Day's High

    ₹762.15
    ₹785
    downward going graph

    0.64%

    Downside

    2.34%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹435.25
    ₹832
    downward going graph

    43.26%

    Downside

    8.47%

    Upside

    downward going graph

Senores Pharmaceuticals Ltd share price movements today

Previous Close
₹787.90
Open
₹767.60
Volume
1.70L
Upper Circuit
₹945.45
Lower Circuit
₹630.35
Day's Low - High
₹762.15 - ₹785
52 Week Low - High
₹435.25 - ₹832

Senores Pharmaceuticals Ltd Historical Returns

1 Month Return
+ 9.86 %
3 Month Return
+ 19.05 %
1 Year Return
+ 41.44 %
3 Year Return
+ 41.44 %
5 Year Return
+ 41.44 %

Senores Pharmaceuticals Ltd Fundamentals

as on November 11, 2025 at 2:59 pm IST

Market Cap

₹3,628.56 Cr

Return on Equity (ROE)

0.84

PE Ratio (TTM)

39.41

Return on capital employed (ROCE)

2.15

Industry PE ratio

41.62

Beta (LTM)

1.48

P/B Ratio

3.73

Dividend Yield

0

PEG Ratio

61.59

Quarterly Earnings Growth YOY

130.45

EPS (TTM)

12.67

Sector

Pharmaceuticals

Book Value

170.72

Technical Analysis

Bullish

View Technical Analysis

Senores Pharmaceuticals Ltd Stock Valuation

as on November 11, 2025 at 2:59 pm IST

Senores Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (21.80x)

January 13, 2025

Today (39.41x)

November 10, 2025

Industry (41.62x)

November 10, 2025

Highest (42.91x)

September 8, 2025

LowHigh

Today’s Price to Earnings Ratio: 39.41x

Senores Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Senores Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Senores Pharmaceuticals Ltd image
Senores Pharmaceuticals Ltd
BUY3,628.568.29%0.6558398
Medicamen Organics Ltd image
Medicamen Organics Ltd
NA33.46-16.05%0.65438
Veerhealth Care Ltd image
Veerhealth Care Ltd
NA35.3868.23%0.00116
Influx Healthtech Ltd image
Influx Healthtech Ltd
NA437.899.98%0.0013104
Aarti Drugs Ltd image
Aarti Drugs Ltd
BUY4,785.22-3.43%0.661682,387
See all

Analyst Recommendation on Senores Pharmaceuticals Ltd Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Senores Pharmaceuticals Ltd. Average target price of ₹894

Source: S&P Global Market Intelligence

Senores Pharmaceuticals Ltd Share Price Target

Get share price movements and forecasts by analysts on Senores Pharmaceuticals Ltd.

What analysts predicted

13.47%UPSIDE

Target Price

₹894

Current Price

₹767.05

Analyzed by

4 Analysts

High

₹960

Target

₹894.00

Low

₹850

Senores Pharmaceuticals Ltd target price ₹894, a slight upside of 13.47% compared to current price of ₹767.05. According to 4 analysts rating.

Source: S&P Global Market Intelligence

Senores Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest

Search interest for Senores Pharmaceuticals Ltd Stock has increased by 103% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:103% versus previous 30 day period

Senores Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
78.7
102.44
79.5
98.26
103.02
104.87
130.3
153.36
Other Income
0.8
1.96
0.48
1.86
5.16
11.77
3.36
5.41
Total Income
79.5
104.4
80.87
102.49
108.18
125.98
141.35
167.17
Expenses
63.55
80.05
59.07
77.36
77.33
94.77
103.83
112.25
Operating Profit
15.15
22.39
20.43
20.9
25.69
10.1
26.47
41.11
Operating Profit Margin %
19.25%
21.86%
25.7%
21.27%
24.94%
9.63%
20.31%
26.81%
Profit Before Interest, Tax and Depreciation
15.95
24.35
21.8
25.13
30.85
31.21
37.52
54.92
Interest
2.45
3.03
4.82
5.27
6.16
5.3
5.04
6.19
Depreciation
3.25
3.71
3.52
3.89
4.2
5.23
5.99
8.09
Profit Before Tax
10.25
17.61
13.46
15.97
20.49
20.68
26.49
40.64
Tax Paid
3.14
3.43
2.55
2.9
4.06
2.71
5.31
10.52
Profit After Tax
7.11
14.18
10.91
13.07
16.43
17.97
21.18
30.12
Total Net profit including share of profit / Loss from associate company
7.11
14.18
10.91
13.07
16.43
17.97
21.18
30.12
EPS
4.01
8.03
3.39
3.92
5.04
3.81
4.6
6.54
Actual EPS
4.01
8.03
3.39
3.92
5.04
3.81
4.6
6.54
Adjusted EPS
4.01
8.03
3.39
3.92
5.04
3.81
4.6
6.54
Diluted EPS
3.47
8.03
3.39
3.92
5.04
3.81
4.6
6.54

Senores Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
14.17
35.34
214.52
377.98
Other Income
0.46
3.68
2.82
19.26
Total Income
14.63
39.02
217.34
417.51
Expenses
12.22
22.67
172.92
308.55
Operating Profit
1.95
12.67
41.6
69.43
Operating Profit Margin %
13.76%
35.85%
19.39%
18.37%
Profit Before Interest, Tax and Depreciation
2.41
16.35
44.42
108.96
Interest
0.57
2.14
9.45
21.55
Depreciation
0.71
1.78
10.02
16.84
Profit Before Tax
1.13
12.43
24.95
70.57
Tax Paid
0.15
4.01
-7.76
12.23
Profit After Tax
0.99
8.43
32.71
58.34
Total Net profit including share of profit / Loss from associate company
0.99
8.43
32.71
58.34
EPS
1.2
8.87
13.67
16.12
Actual EPS
1.2
8.87
13.67
16.12
Adjusted EPS
1.2
8.87
13.67
16.12
Diluted EPS
1.2
6.65
12.21
16.12

Senores Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-10.45
-1.08
-25.7
-45.92
Cash Flow from Investing Activities
-24.44
-48.29
-53.73
-429.48
Cash Flow from Financing Activities
36.46
46.25
86.98
573.13
Net Cash Flow
1.58
-3.12
7.55
97.73

Senores Pharmaceuticals Ltd Stock Shareholding Pattern

Numbers in percentages

Jul 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
66.66%
45.76%
45.76%
45.77%
45.78%
45.8%
DII
0%
18.61%
11.78%
9.65%
9.51%
8.61%
FII
0%
5.51%
4.25%
4.17%
3.67%
4.28%
Public
0%
30.11%
38.2%
40.4%
41.04%
41.31%
Total Outstanding Shares
3,32,65,865
4,60,53,588
4,60,53,588
4,60,53,588
4,60,53,588
4,60,53,588
Total Shareholders
177
43,707
49,518
37,653
36,389
34,917

Mutual Funds that own Senores Pharmaceuticals Ltd Stock

Check out the Mutual Funds with significant holdings in Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Senores Pharmaceuticals Ltd.

  • Senores Pharmaceuticals Ltd Earnings Results

    Senores Pharmaceuticals Ltd’s net profit jumped 152.18% since last year same period to ₹32.38Cr in the Q2 2025-2026. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated 64.12% jump in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Senores Pharmaceuticals Ltd Stock

Check stock indices that include Senores Pharmaceuticals Ltd.

BSE IPO

₹15,849.26

-0.04 (▲-6.74%)

BSE Healthcare

₹44,253.78

-0.28 (▲-123.44%)

BSE Small-Cap

₹52,843.42

-0.11 (▲-57.61%)

Insights on Senores Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, SENORES stock has moved up by 54.3%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 41.04% to 41.31% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.67% to 4.28% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 3.00% to 3.54% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 45.78% to 45.80% in Sep 2025 quarter

About Senores Pharmaceuticals Ltd

Senores Pharmaceuticals Limited was originally incorporated as Senores Pharmaceuticals Private Limited through a Certificate of Incorporation dated December 26 2017 issued by the Registrar of Companies Central Registration Centre. Thereafter the name of the Company was changed to Senores Pharmaceuticals Limited upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4 2023 was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms. The Regulated Markets business is focused on Regulated Markets of US and Canada. The Company has adopted a strategy of identifying developing and commercializing specialty and complex niche products in the midmarket range and received approvals for 19 ANDAs. Further it develop and manufacture pharmaceutical products across various therapeutic areas for Emerging Markets having a presence across 43 countries. The Company operate a Critical Care Injectables Business supplying critical care injectables to hospitals across India through distributors and manufacture APIs for the domestic market and SAARC countries.In 2021 the Company incorporated a wholly owned subsidiary Senores Pharmaceuticals Inc in the US. It then entered the new segment of API by acquiring Ratnagene Lifescience Private Limited. The Company started domestic business with the launch of the Critical Care Injectables Business in 2022.The Company further acquired majority stake in Havix Group Inc. making it a subsidiary of the Company in 2023. It consolidated presence in emerging markets by acquiring shares in Ratnatris Pharmaceuticals Private Limited making it a Subsidiary of the Company in 2023. The Company has launched CMO product in the US with Jubilant Cadista Pharmaceuticals Inc. in 2024. The Company is planning to raise money from public through IPO by issue and allotment of 2700000 Equity Shares through Offer for Sale and Rs 500 Crores equity funds through Fresh Issue..

Revenue: ₹153.36Cr as on September 2025 (Q2 FY26)
Net Profit: ₹30.12Cr as on September 2025 (Q2 FY26)
Listing date: 30 Dec, 2024
Chairperson Name: Sanjay Majmudar
OrganisationSenores Pharmaceuticals Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOSanjay Majmudar
E-voting on sharesClick here to vote

FAQs

What is Senores Pharmaceuticals Ltd share price today?

Senores Pharmaceuticals Ltd share price today stands at ₹767.05 as on . Senores Pharmaceuticals Ltd share today touched a day high of ₹785 and a low of ₹762.15.

What is the 52 week high and 52 week low range for Senores Pharmaceuticals Ltd share?

Senores Pharmaceuticals Ltd touched a 52 week high of ₹832 and a 52 week low of ₹435.25. Senores Pharmaceuticals Ltd share price today i.e. is trending at ₹767.05, which is -7.81% down from its 52 week high and 76.23% up from its 52 week low.

What is Senores Pharmaceuticals Ltd's market capitalisation today?

Senores Pharmaceuticals Ltd market capitalisation is ₹3,628.56 Cr as on .

How to buy Senores Pharmaceuticals Ltd shares?

To buy Senores Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SENORES or Senores Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Senores Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Senores Pharmaceuticals Ltd trading volume today?

Senores Pharmaceuticals Ltd trading volume is 1.70L as on . This means that 1.70L shares of Senores Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.